Advances in plant polysaccharide research for neurodegenerative diseases therapy
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-13064-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 04.11.2026. Verfasst von Bai-He He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Changchun University of Chinese Medicine, School of Chinese Medicine, Changchun, 130117, Jilin, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Polysaccharides, Neuroprotective Agents, Plants. Die Arbeit nennt 91 Literaturangaben.
Abstract (Originalsprache)
Neurodegenerative diseases (NDs), including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), represent a growing global public health burden with limited therapeutic options. Plant polysaccharides are natural, biocompatible, and multi-target bioactive macromolecules that have emerged as promising candidates for ND intervention. This review systematically summarizes recent progress in elucidating the structural characteristics, structure-activity relationships, and neuroprotective mechanisms of plant polysaccharides. Key structural features such as molecular weight, monosaccharide composition, glycosidic bond configuration, and spatial conformation critically modulate the biological activity of these molecules. Furthermore, we summarize the numerous protective effects of plant polysaccharides against NDs, including inhibiting abnormal protein aggregation, alleviating oxidative stress via the Nrf2/HO-1 pathway, suppressing neuroinflammation through the NF-κB and MAPK signaling pathways, regulating neuronal apoptosis, and modulating the gut-brain axis. Clinical translation challenges, primarily blood-brain barrier penetration, structural heterogeneity, and insufficient clinical validation, are discussed. Future directions include developing advanced delivery systems, conducting large-scale randomized controlled trials, and exploring synergistic combination therapies. Collectively, plant polysaccharides show considerable promise as potential multi-target candidates for the intervention of NDs, although further studies are needed to clarify their therapeutic potential and facilitate clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Changchun University of Chinese Medicine, School of Chinese Medicine, Changchun, 130117, Jilin, China.
- The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Office of Drug Clinical Trial Institutions, Changchun, 130021, Jilin, China.
- College of Traditional Chinese Medicine, Jilin Agricultural Science and Technology University, Changchun, 132101, Jilin, China.
- Changchun University of Chinese Medicine, School of Chinese Medicine, Changchun, 130117, Jilin, China. zhaojianjun8777@163.com.
- Department of Encephalopathy, The Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, 130021, Jilin, China. zhaojianjun8777@163.com.
Zitieren
APA
He, B. H., Yang, W., Yang, M., Lv, X., & Zhao, J. J. (2026). Advances in plant polysaccharide research for neurodegenerative diseases therapy. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13064-3
Vancouver
He BH, Yang W, Yang M, Lv X, Zhao JJ. Advances in plant polysaccharide research for neurodegenerative diseases therapy. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13064-3
BibTeX
@article{He2026,
author = {He, Bai-He and Yang, Wei and Yang, Min and Lv, Xin and Zhao, Jian-Jun},
title = {Advances in plant polysaccharide research for neurodegenerative diseases therapy},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-13064-3}
}
EUVIMED